Effects of Hydroxychloroquine in Patients With Cutaneous Lupus Erythematosus: A Multicenter, Double-Blind, Randomized, Parallel-Group Trial
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effects of Hydroxychloroquine in Patients With Cutaneous Lupus Erythematosus: A Multicenter, Double-Blind, Randomized, Parallel-Group Trial
Authors
Keywords
-
Journal
Arthritis & Rheumatology
Volume 69, Issue 4, Pages 791-799
Publisher
Wiley
Online
2016-12-20
DOI
10.1002/art.40018
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sifalimumab, an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study
- (2016) Munther Khamashta et al. ANNALS OF THE RHEUMATIC DISEASES
- Population Pharmacokinetics of Hydroxychloroquine in Japanese Patients With Cutaneous or Systemic Lupus Erythematosus
- (2016) Shigemichi Morita et al. THERAPEUTIC DRUG MONITORING
- Treat-to-target in systemic lupus erythematosus: recommendations from an international task force
- (2014) Ronald F van Vollenhoven et al. ANNALS OF THE RHEUMATIC DISEASES
- Effects of Hydroxychloroquine on Symptomatic Improvement in Primary Sjögren Syndrome
- (2014) Jacques-Eric Gottenberg et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Response to hydroxychloroquine in Japanese patients with lupus-related skin disease using the cutaneous lupus erythematosus disease area and severity index (CLASI)
- (2014) Naoto Yokogawa et al. Modern Rheumatology
- Therapeutic strategies evaluated by the European Society of Cutaneous Lupus Erythematosus (EUSCLE) Core Set Questionnaire in more than 1000 patients with cutaneous lupus erythematosus
- (2012) Johanna Sigges et al. AUTOIMMUNITY REVIEWS
- Use of Hydroxychloroquine in Japan
- (2012) M. KISHIMOTO et al. JOURNAL OF RHEUMATOLOGY
- Development of the CLASI as a Tool to Measure Disease Severity and Responsiveness to Therapy in Cutaneous Lupus Erythematosus
- (2011) Rachel Klein et al. ARCHIVES OF DERMATOLOGY
- Response to Antimalarial Agents in Cutaneous Lupus Erythematosus
- (2011) Aileen Y. Chang ARCHIVES OF DERMATOLOGY
- Mechanism of Endosomal TLR Inhibition by Antimalarial Drugs and Imidazoquinolines
- (2011) A. Kuznik et al. JOURNAL OF IMMUNOLOGY
- Quantitative Data for Care of Patients with Systemic Lupus Erythematosus in Usual Clinical Settings: A Patient Multidimensional Health Assessment Questionnaire and Physician Estimate of Noninflammatory Symptoms
- (2011) A. D. ASKANASE et al. JOURNAL OF RHEUMATOLOGY
- Antimalarial treatment may have a time-dependent effect on lupus survival: Data from a multinational Latin American inception cohort
- (2010) Samuel K. Shinjo et al. ARTHRITIS AND RHEUMATISM
- The protective effect of antimalarial drugs on thrombovascular events in systemic lupus erythematosus
- (2010) Hyejung Jung et al. ARTHRITIS AND RHEUMATISM
- Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohort
- (2009) Guillermo J. Pons-Estel et al. ARTHRITIS AND RHEUMATISM
- Predictors of major infections in systemic lupus erythematosus
- (2009) Guillermo Ruiz-Irastorza et al. ARTHRITIS RESEARCH & THERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started